The Effect of Breast Cancer Prevention Journey Program

July 9, 2024 updated by: Nurbanu Odacı

The Effect of Breast Cancer Prevention Journey Program on Women's Health Beliefs Towards Breast Cancer: Quasi Experimental Study

The aim of this quasi-experimental study is to determine the effect of the "Breast Cancer Prevention Journey Program" on health beliefs about breast cancer in women over 40 years of age who have never had a mammogram before. The research aims to answer the following basic questions:

-Do women who participated in the "Breast Cancer Prevention Journey Program" have different health beliefs about breast cancer than women who did not participate in the program? The researchers will compare the program with routine care to see if the "Breast Cancer Prevention Journey Program" works. The study will be conducted in a quasi-experimental design with a pre-test post-test control group.

Participants in the experimental group will first participate in the "The fight against breast cancer" training structured according to the Health Belief Model. One week after the training, the participants in the experimental group will be taken to mammography screening with free shuttles.

Participants in the control group will not receive any additional intervention. This group will only receive routine intervention within the scope of the breast cancer screening program conducted by the Ministry of Health.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Çankaya
      • Ankara, Çankaya, Turkey, 06510
        • Lokman Hekim Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a woman between the ages of 40-69
  • Having never had a mammogram before

Exclusion Criteria:

  • Being diagnosed with breast cancer
  • Having had a breast operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breast Cancer Prevention Journey Program Group
Participants will first receive structured "The Fighting Breast Cancer" training based on the Health Belief Model. Then they will be taken to mammography screening with a free transportation service and will be screened for cancer.
Other: Breast Cancer Prevention Journey Program Group
The researcher will invite individuals to the study at Necip Fazıl Family Center and conduct a pre-test application. The day and time for the "Fight Against Breast Cancer" training, which is structured based on the Health Belief Model prepared by the researchers, will be determined and announced to the participants. The training will be held in a single session of 45-60 minutes. Slide presentation and a breast model showing the symptoms of breast cancer will be used as training materials. At the end of the training, it will be announced that free shuttle service will be provided for mammography screening and individuals will be invited to screening. On the specified day and time, participants will be taken to the "Cancer Early Diagnosis, Screening and Education Center (KETEM)" in Mamak and mammography screening will be performed. After the screening, a post-test will be performed.
Other: Routine Cancer Screening Program Group
Participants in the control group will not receive any additional intervention. This group will only receive routine intervention within the scope of the breast cancer screening program conducted by the Ministry of Health.
Other: Routine Cancer Screening Program Group
Participants in the control group will not receive any additional intervention. This group will only receive routine intervention within the scope of the breast cancer screening program conducted by the Ministry of Health. Health Ministry of Türkiye offers free mammography screening for breast cancer to women over the age of 40. In this context, women are called to the centers by phone and mammography screening is performed free of charge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Champion's Health Belief Model Scale in Breast Cancer Screening
Time Frame: two week
This scale was developed to assess women's breast cancer beliefs (1984) and adapted into Turkish in 2004 (2004). It has a total of 52 items. It is a 5-point Likert-type scale. No single total score is obtained from the scale. The 8 sub-dimensions of the scale and the minimum and maximum scores that can be obtained are as follows; "Perception of sensitivity (min:3; max:15)", "Perception of severity (min:6; max:30)", "Perception of health motivation (min:5; max:25)", "Perception of benefit of breast self-examination (BSE) (min: 4; max:20)", 'Perception of benefit of breast self-examination (CBM) (min:10; max:50)', 'Barriers to CBM (min:8; max:40)', 'Perception of benefit of mammography (min:5; max:25)' and 'Barriers to mammography (min:11; max:55)'. Scale subscale scores are calculated by summing the scores. An increase in score is associated with a positive attitude in all sub-dimensions except the barrier sub-dimension. The Cronbach's Alpha value of the scale is between 0.69 and 0.83.
two week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nurbanu Odacı

Collaborators

The Scientific and Technological Research Council of Turkey

Investigators

  • Principal Investigator: Nurbanu Odacı, Master, Lokman Hekim Universty

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2024

Primary Completion (Actual)

May 31, 2024

Study Completion (Actual)

June 28, 2024

Study Registration Dates

First Submitted

April 28, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Actual)

May 2, 2024

Study Record Updates

Last Update Posted (Actual)

July 10, 2024

Last Update Submitted That Met QC Criteria

July 9, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LokmanHekimU-Hem-NO-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer Female

Clinical Trials on Breast Cancer Prevention Journey Program Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe